🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

Roluperidone

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases, including schizophrenia and Parkinson's disease.

Tags: Parkinson's disease, biopharmaceutical, central nervous system, neurodegenerative disorders, schizophrenia

Website

About | Leadership | Directors | Contact | ESG

Symbol: NERV

Recent Price: $2.29

Industry: Biotechnology

CEO: Dr. Remy Luthringer Ph.D.

Sector: Healthcare

Employees: 9

Address: 1601 Trapelo Road, Waltham, MA 02451

Phone: 617 600 7373

Leadership

  • Remy Luthringer, PhD, Executive Chairman of the Board, Chief Executive Officer
  • Geoff Race, FCMA, MBA, President
  • Michael Davidson, M.D., Chief Medical Officer
  • Frederick Ahlholm, CPA, Chief Financial Officer
  • Joseph Reilly, Senior Vice President and Chief Operating Officer
  • Jay Saoud, PhD, Consultant
  • Hans Peter Hasler, Board Member
  • Jan van Heek, Board Member
  • David Kupfer, MD, Board Member
  • Fouzia Laghrissi-Thode, MD, Board Member, Chief Executive Officer of DalCor Pharmaceuticals

Last updated: 2024-12-31